Oppenheimer & Co. Inc. Sells 6,000 Shares of Enhabit, Inc. (NYSE:EHAB)

Oppenheimer & Co. Inc. cut its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 26.4% during the third quarter, Holdings Channel reports. The fund owned 16,699 shares of the company’s stock after selling 6,000 shares during the period. Oppenheimer & Co. Inc.’s holdings in Enhabit were worth $132,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Gladius Capital Management LP bought a new stake in Enhabit during the 2nd quarter worth approximately $31,000. Quarry LP grew its position in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares during the last quarter. ProShare Advisors LLC bought a new stake in Enhabit during the 1st quarter worth approximately $118,000. Stoneridge Investment Partners LLC bought a new stake in Enhabit during the 3rd quarter worth approximately $81,000. Finally, Canada Pension Plan Investment Board bought a new position in Enhabit in the 2nd quarter valued at $93,000.

Analyst Upgrades and Downgrades

Separately, Leerink Partners reiterated a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $9.25.

Enhabit Stock Performance

EHAB stock opened at $7.56 on Friday. The business’s fifty day moving average is $7.50 and its 200-day moving average is $8.40. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company has a market cap of $380.12 million, a P/E ratio of -3.26 and a beta of 1.84. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the company earned $0.03 EPS. Equities research analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.